DelveInsight’s ‘Gout Pipeline Insights’ report offers comprehensive coverage of the emerging Gout therapeutics landscape in different stages of development from pre-clinical till a late-end stage, along with dormant, inactive, and abandoned drugs agents.
The Gout Pipeline report provides a holistic picture of the ongoing clinical trials, partnerships taking place in the domain, recent happenings in space, and growth prospects across the Gout domain.
Around 40+ key companies are developing therapies for Gout. Selecta Biosciences appears to have the upper leg being the only company with its Gout drug candidate in the most advanced stage (Phase III).
Some of the key highlights from the Gout Pipeline report:
Request for Sample to know more about the therapies that are set to grab maximum patient pool @ https://www.delveinsight.com/sample-request/gouty-arthritis-gout-pipeline-insight
Gout is a chronic disease that is caused due to excess accumulation of uric acid in the body, a condition referred to as hyperuricemia. It is a painful and crystal-induced form of arthritis in which crystals of monosodium urate (MSU) precipitate and deposit in joints of lower limbs. Gout is treatable with medications and changes in diet and lifestyle.
Gout Pipeline Drugs
Drug
Company
Phase
MoA
RoA
SEL-212
Selecta Biosciences
Phase III
Urate oxidase replacements
Intravenous
SHR4640
Jiangsu Hengrui Medicine Co.
SLC22A12 protein inhibitors
Oral
LC350189
LG Chem
Phase II
Xanthine oxidase inhibitors
URC-102
JW Pharmaceutical
Dapansutrile
Olatec Therapeutics
Inflammasome inhibitors; Interleukin inhibitors; NLRP3 protein inhibitors
TMX-049
Teijin Pharma
NA
SAP-001
Shanton Pharma
Urate transporter inhibitors
XNW3009
Sinovent
Phase I
PRX-115
Protalix BioTherapeutics
Preclinical
NC-2700
Nippon Chemiphar
HZN-003
Horizon Therapeutics
Enzyme replacements
Subcutaneous
Request for Sample to know more @ https://www.delveinsight.com/sample-request/gouty-arthritis-gout-pipeline-insight
Gout Therapeutic Assessment
The Gout Pipeline report lays down complete insights into active Gout pipeline therapies segmented by Stage, Product Type, Route of Administration, Molecule Type, Target, and Mechanism of Action.
Scope of the Report
Coverage: Global Key Players: Protalix BioTherapeutics, Shanton Pharma, Horizon Therapeutics, JW Pharmaceutical, Jiangsu Hengrui Medicine Co., Nippon Chemiphar, Sinovent, LG Chem, Selecta Biosciences, TWi Biotechnology, Olatec Therapeutics, Hinova pharmaceuticals, Dyve Biosciences, InventisBio, Arrowhead Pharmaceuticals, Wellstat Therapeutics Corporation, Acquist Therapeutics, TaiwanJ Pharmaceuticals, Atom Bioscience
Key Gout Pipeline Therapies: PRX-115, SAP-001, HZN-003, URC-102, SHR4640, NC-2700, XNW3009, LC350189, SEL-212, AC-201, Dapansutrile, HP501, DYV700, D-0120, ARO-XDH, WT-2107, ACQT1127, TJC0434, ABP-072, and many others.
Reach out @ https://www.delveinsight.com/sample-request/gouty-arthritis-gout-pipeline-insight
Table of Contents
1
Report Introduction
2
Gout Disease Overview
3
Gout Pipeline Outlook
4
Comparative Analysis
5
Gout Therapeutic Products in Clinical Stage
6
Gout Late Stage Products (Phase III)
6.1
SEL-212: Selecta Biosciences
6.2
SHR4640: Jiangsu Hengrui Medicine Co.
7
Gout Mid Stage Products (Phase II)
7.1
LC350189: LG Chem
7.2
URC-102: JW Pharmaceutical
7.3
SAP-001: Shanton Pharma
8
Gout Early Stage Products (Phase I)
8.1
XNW3009: Sinovent
9
Gout Therapeutic Products in Non-clinical Stage
10
Gout Preclinical and Discovery Stage Products
10.1
HZN-003: Horizon Therapeutics
10.2
PRX-115: Protalix BioTherapeutics
11
Gout Therapeutics Pipeline Analysis
12
Inactive Gout Pipeline Products
13
Appendix
14
Report Methodology
15
Consulting Services
16
Disclaimer
17
About DelveInsight
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/gouty-arthritis-gout-pipeline-insight